Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Detalles Bibliográficos
Autores principales: Mishto, Michele, Rodriguez-Hernandez, Guillermo, Neefjes, Jacques, Urlaub, Henning, Liepe, Juliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315000/
https://www.ncbi.nlm.nih.gov/pubmed/34326838
http://dx.doi.org/10.3389/fimmu.2021.679836
_version_ 1783729650602606592
author Mishto, Michele
Rodriguez-Hernandez, Guillermo
Neefjes, Jacques
Urlaub, Henning
Liepe, Juliane
author_facet Mishto, Michele
Rodriguez-Hernandez, Guillermo
Neefjes, Jacques
Urlaub, Henning
Liepe, Juliane
author_sort Mishto, Michele
collection PubMed
description
format Online
Article
Text
id pubmed-8315000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83150002021-07-28 Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients Mishto, Michele Rodriguez-Hernandez, Guillermo Neefjes, Jacques Urlaub, Henning Liepe, Juliane Front Immunol Immunology Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8315000/ /pubmed/34326838 http://dx.doi.org/10.3389/fimmu.2021.679836 Text en Copyright © 2021 Mishto, Rodriguez-Hernandez, Neefjes, Urlaub and Liepe https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Mishto, Michele
Rodriguez-Hernandez, Guillermo
Neefjes, Jacques
Urlaub, Henning
Liepe, Juliane
Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_fullStr Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full_unstemmed Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_short Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_sort response: commentary: an in silico–in vitro pipeline identifying an hla-a*02:01+ kras g12v+ spliced epitope candidate for a broad tumor-immune response in cancer patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315000/
https://www.ncbi.nlm.nih.gov/pubmed/34326838
http://dx.doi.org/10.3389/fimmu.2021.679836
work_keys_str_mv AT mishtomichele responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT rodriguezhernandezguillermo responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT neefjesjacques responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT urlaubhenning responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients
AT liepejuliane responsecommentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients

Ejemplares similares